This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Recent over-the-counter (OTC) approvals for CGM systems are transforming diabetes management and lifestyle management for those without diabetes, making this an exciting time for healthcare professionals and their patients. Plus, understand the broader implications of these innovations for expanding access and advancing health equity.
We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge. One promising strategy is the formation of creative partnerships between patients and their healthcare teams.
Promoting heart-healthy lifestyles, such as maintaining a balanced diet, staying physically active, and quitting smoking, can save lives. Encouraging Regular Check-ups: Cardiologists play a vital role in promoting preventive care.
Tirzepatide Approval Date: December 19, 2024 Indication: Moderate to severe obstructive sleep apnea (OSA) in adults with obesity, combined with a reduced-calorie diet and increased physical activity. By prioritizing patient-centric innovation, these advancements emphasize the importance of addressing unmet medical needs.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Diet 
105 
Let's personalize your content